Interleukin-10 Promoter Polymorphism in Psoriasis
- 1 June 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 116 (6), 975-978
- https://doi.org/10.1046/j.1523-1747.2001.01350.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequenciesGenes & Immunity, 2000
- Combined Analysis of Polymorphisms of the Tumor Necrosis Factor-α and Interleukin-10 Promoter Regions and Polymorphic Xenobiotic Metabolizing Enzymes in PsoriasisJournal of Investigative Dermatology, 1999
- A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor ? overexpressionBritish Journal of Dermatology, 1999
- Treatment of Psoriasis with Interleukin-10Journal of Investigative Dermatology, 1998
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.Journal of Clinical Investigation, 1998
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Monte Carlo tests for associations between disease and alleles at highly polymorphic lociAnnals of Human Genetics, 1995
- Keratinocyte Interleukin-10 Expression Is Upregulated in Tape-Stripped Skin, Poison Ivy Dermatitis, and Sezary Syndrome, but Not in Psoriatic PlaquesClinical Immunology and Immunopathology, 1994
- Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients relationships with disease severityClinical and Experimental Dermatology, 1994
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986